Springworks Therapeutics Stock Market Value
| SWTX Stock | USD 39.02 2.72 7.49% |
| Symbol | SpringWorks |
SpringWorks Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SpringWorks Therapeutics. If investors know SpringWorks will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SpringWorks Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.89) | Revenue Per Share 1.885 | Return On Assets (0.34) | Return On Equity (0.59) |
The market value of SpringWorks Therapeutics is measured differently than its book value, which is the value of SpringWorks that is recorded on the company's balance sheet. Investors also form their own opinion of SpringWorks Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is SpringWorks Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SpringWorks Therapeutics' market value can be influenced by many factors that don't directly affect SpringWorks Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SpringWorks Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if SpringWorks Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SpringWorks Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
SpringWorks Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SpringWorks Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SpringWorks Therapeutics.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in SpringWorks Therapeutics on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding SpringWorks Therapeutics or generate 0.0% return on investment in SpringWorks Therapeutics over 30 days. SpringWorks Therapeutics is related to or competes with Relay Therapeutics, Stoke Therapeutics, Pliant Therapeutics, Black Diamond, Arvinas, Day One, and Amylyx Pharmaceuticals. SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suff... More
SpringWorks Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SpringWorks Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SpringWorks Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 11.04 | |||
| Value At Risk | (4.36) | |||
| Potential Upside | 4.46 |
SpringWorks Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for SpringWorks Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SpringWorks Therapeutics' standard deviation. In reality, there are many statistical measures that can use SpringWorks Therapeutics historical prices to predict the future SpringWorks Therapeutics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.46) | |||
| Treynor Ratio | (0.15) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of SpringWorks Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
SpringWorks Therapeutics Backtested Returns
SpringWorks Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0346, which indicates the firm had a -0.0346% return per unit of risk over the last 3 months. SpringWorks Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate SpringWorks Therapeutics' Risk Adjusted Performance of (0.02), variance of 7.81, and Coefficient Of Variation of (3,092) to confirm the risk estimate we provide. The entity has a beta of 0.66, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, SpringWorks Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding SpringWorks Therapeutics is expected to be smaller as well. At this point, SpringWorks Therapeutics has a negative expected return of -0.1%. Please make sure to validate SpringWorks Therapeutics' skewness, as well as the relationship between the daily balance of power and day typical price , to decide if SpringWorks Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.79 |
Good predictability
SpringWorks Therapeutics has good predictability. Overlapping area represents the amount of predictability between SpringWorks Therapeutics time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SpringWorks Therapeutics price movement. The serial correlation of 0.79 indicates that around 79.0% of current SpringWorks Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.79 | |
| Residual Average | 0.0 | |
| Price Variance | 3.66 |
SpringWorks Therapeutics lagged returns against current returns
Autocorrelation, which is SpringWorks Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting SpringWorks Therapeutics' stock expected returns. We can calculate the autocorrelation of SpringWorks Therapeutics returns to help us make a trade decision. For example, suppose you find that SpringWorks Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
SpringWorks Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If SpringWorks Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if SpringWorks Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in SpringWorks Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
SpringWorks Therapeutics Lagged Returns
When evaluating SpringWorks Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of SpringWorks Therapeutics stock have on its future price. SpringWorks Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, SpringWorks Therapeutics autocorrelation shows the relationship between SpringWorks Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in SpringWorks Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SpringWorks Stock Analysis
When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.